KYIV. Feb 27 (Interfax-Ukraine) – The net profit of Lekhim pharmaceutical company (Kyiv) in 2016 amounted to UAH 95.915 million, which is 19% more than in 2015 (UAH 80.602 million).
Lekhim reported in the announcement of the next general shareholders’ meeting to be held on March 28, its net worth for the reporting period increased by 52%, from UAH 169.747 million to UAH 258.695 million.
The company’s assets increased by less than 1% and amounted to UAH 589.628 million.
JSC Lekhim was founded in 1992. The group of companies headed by Lekhim includes Lekhim-Kharkiv, PJSC Tekhnolog (Uman).
Lekhim produces more than 130 items of pharmaceutical goods. The group exports its products to Belarus, Kazakhstan, Turkmenistan, Russia, Moldova, Georgia, Uzbekistan, Armenia, and Azerbaijan.
